RhumbLine Advisers’s Benitec Biopharma BNTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $244K | Buy |
20,858
+20,672
| +11,114% | +$242K | ﹤0.01% | 3119 |
|
|
2025
Q1 | $2.42K | Hold |
186
| – | – | ﹤0.01% | 3968 |
|
|
2024
Q4 | $2.35K | Hold |
186
| – | – | ﹤0.01% | 4026 |
|
|
2024
Q3 | $1.71K | Hold |
186
| – | – | ﹤0.01% | 4066 |
|
|
2024
Q2 | $1.3K | Hold |
186
| – | – | ﹤0.01% | 4217 |
|
|
2024
Q1 | $952 | Hold |
186
| – | – | ﹤0.01% | 4149 |
|
|
2023
Q4 | $602 | Hold |
186
| – | – | ﹤0.01% | 4194 |
|
|
2023
Q3 | $561 | Hold |
186
| – | – | ﹤0.01% | 4224 |
|
|
2023
Q2 | $752 | Buy |
+186
| New | +$752 | ﹤0.01% | 4297 |
|